Our Science
Supporting Publications
Through our scientific publications and research projects, we are accelerating and transforming personalized patient care.
Nature Communications
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers
2025
Molecular Systems Biology
Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer
2025
Nature Communications
Cell facilitation promotes growth and survival under drug pressure in breast cancer
2023
Molecular Systems Biology
ENDORSE: a prognostic model for endocrine therapy in estrogen-receptor-positive breast cancers
2022
Nature Cancer
Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy
2021